川崎医科大学附属病院HP学生・医師の方へ
  Department of Dermatology,
Kawasaki Medical School Hospital
HOME 外来診療表 医師紹介 診療概要 学生・医師の方へ

 Hospital
    外来診療表
    医師紹介
    診療概要
    受診予約について
    関連病院
    アクセス方法
 Medical School
    医局アルバム
    業績
    見学申込
    リンク集

 川崎医科大学附属病院              皮膚科
  〒701-0192
     岡山県倉敷市松島577
   TEL 086-462-1111
   FAX 086-462-1199

 業績

 1. Yamamoto T, Hirai Y, Miyake T, Hamada T, Yamasaki O, Morizane S, Fujimoto W, Iwatsuki K.
Epstein-Barr virus reactivation is induced, but abortive, in cutaneous lesions of systemic hydroa vacciniforme and hypersensitivity to mosquito bites. J Dermatol Sci. 2016 Mar 5. pii: S0923-1811(16)30023-8. doi: 10.1016/j.jdermsci.2016.03.001. [Epub ahead of print] PMID: 27039668
 2. Makino M, Sasaoka S, Nakanishi G, Makino E, Fujimoto W.
Congenital atrophic dermatofibrosarcoma protuberans detected by COL1A1-PDGFB rearrangement. Diagn Pathol. 2016 Mar 1;11(1):24. doi: 10.1186/s13000-016-0474-6. PMID: 26932148
 3. Tanaka R, Inagawa K, Kanomata N, Hata J, Fujimoto W.
Photoletter to the editor: Pigmented dermatofibrosarcoma protuberans in a 4-year-old girl and ultrasonographic findings. J Dermatol Case Rep. 2015 Jun 30;9(2):52-4. doi: 10.3315/jdcr.2015.1201. eCollection 2015 Jun 30. PMID: 26236415
 4. Oka D, Hayashi H, Fujimoto W.
Refractory eosinophilic pustular folliculitis resistant to oral indomethacin successfully treated with adjuvant topical indomethacin. J Dermatol. 2014 Sep;41(9):860-1. doi: 10.1111/1346-8138.12595. No abstract available. PMID: 25182296
 5. Fujimoto W, Matsuo-Kanda A.
Multilocalized non-pigmenting fixed drug eruption caused by triclofos sodium. Eur J Dermatol. 2014 May-Jun;24(3):380-1. doi: 10.1684/ejd.2014.2314. No abstract available. PMID: 24721678
 6. Makino E, Nakano H, Sawamura D, Fujimoto W.
Recessive dystrophic epidermolysis bullosa: identification of a novel COL7A1 mutation of D44N. J Dermatol Sci. 2012 Nov;68(2):109-12. doi: 10.1016/j.jdermsci.2012.07.003. Epub 2012 Jul 16. No abstract available. PMID: 22854212
7. Hayashi H, Kuwabara C, Tarumi K, Makino E, Fujimoto W.
Successful treatment with infliximab for refractory pyoderma gangrenosum associated with inflammatory bowel disease. Journal of Dermatology.Epub ahead of print
8.  Hayashi H, Miura Y, Maeda M, Murakami S, Kumagai N, Nishimura Y, Kusaka M, Urakami K, Fujimoto W, Otsuki T.
Reductive alteration of the regulatory function of the CD4+CD25+ T cell fraction in silicosis patients. Int J Immunopathol Pharmacol. 2010 Oct-Dec;23(4):1099-109
9. Hayashi H:Peripheral regulatory T cell from silicosis patients is susceptible to CD95-mediated apoptosis. Kawasaki Med J.2010;36(1): 13-21.
10. Matsuo A, Tanaka R, Shiotani A, Haruma K, Ishii N, Hashimoto T, Fujimoto W.
Remission of sublamina densa-type linear IgA bullous dermatosis after Helicobacter pylori eradication. Clin Exp Dermatol. 2009 Dec;34(8):e988-9.
11. Hayashi H, Sakai J, Matsuura H, Fujimoto W.
Cyclophosphamide and amniotic membrane transplantation in the management of ocular disease in a case of antiepiligrin cicatricial pemphigoid.Clin Exp Dermatol. 2009 Oct;34(7):e477-9.
12. Hayashi H, Nishimura Y, Maeda M, Murakami S, Kumagai N, Chen Y, Kusaka M, Uragami K, Fujimoto W, Otsuki T.
Is soluble CD40 ligand an indicator of immunopathological disturbance in silicosis patients?Kawasaki Med J.2009;35(2): 129-138.
13. Tanaka R, Nakashima K, Fujimoto W.
Sentinel lymph node detection in skin cancer using fluorescence navigation with indocyanine green.J Dermatol. 2009 Aug;36(8):468-70.
14. Hayashi H, Maeda M, Murakami S, Kumagai N, Chen Y, Hatayama T, Katoh M, Miyahara N, Yamamoto S, Yoshida Y, Nishimura Y, Kusaka M, Fujimoto W, Otsuki T.
Soluble interleukin-2 receptor as an indicator of immunological disturbance found in silicosis patients.Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):53-62.
15. Niitani A, Matsuura H, Kuyama M, Fujimoto W.
Paraneoplastic dermatosis suspected of being Bazex syndrome in a woman with breast cancer. Eur J Dermatol. 2007 Nov-Dec;17(6):557-8.
16. Niitani A, Matsuura H, Fujimoto W.
Fixed food eruption caused by extract of sword bean, canavalia gladiate. J Enviro Dermatol and Cutan Allergo. 2007;(2) 131-4.
17. Makino E, Uchida T, Matsushita Y, Inaoki M, Fujimoto W.
Melanocytic nevi clinically simulating melanoma. J Dermatol. 2007 Jan;34(1):52-5.
18. Tanaka R, Matsuura H, Kobashi Y, Fujimoto W.
Clinical utility of an interferon-gamma-based assay for mycobacterial detection in papulonecrotic tuberculid. Br J Dermatol. 2007 Jan;156(1):169-71.
19. Uchida T, Hayashi H, Inaoki M, Miyamoto T, Fujimoto W.
A failure of mucocutaneous lymphangiogenesis may underlie the clinical features of lipoid proteinosis. Br J Dermatol. 2007 Jan;156(1):152-7.
20. Inaoki M, Echigo T, Hayashi H, Nagaoka T, Hasegawa M, Takehara K, Fujimoto W, Tedder TF, Sato S.
Decreased expression levels of CD22 and L-selectin on peripheral blood B lymphocytes from patients with bullous pemphigoid. J Autoimmun. 2006 Nov;27(3):196-202.
21. Inaoki M, Ishii N, Hashimoto T, Fujimoto W.
Cicatricial pemphigoid with widespread bullous eruption. J Dermatol. 2006 Oct;33(10):727-9.
22. Inaoki M, Makino E, Adachi M, Fujimoto W.
Onycholemmal carcinoma. J Cutan Pathol. 2006 Aug;33(8):577-80.
23. Fujimoto W, Hamada T, Yamada J, Matsuura H, Iwatsuki K.
Bullous Systemic Lupus Erythematosus as an Initial Manifestation of SLE. J Dermatol. 2005 Dec;32(12):1021-7.
24. Makino E, Inaoki M, Fujimoto W.
Inflammatory stage of disseminated superficial porokeratosis. J Dermatol. 2005 Nov;32(11):890-3.
25. Fujimoto W, Inaoki M, Fukui T, Inoue Y, Kuhara T.
Biotin deficiency in an infant fed with amino acid formula. J Dermatol. 2005 Apr;32(4):256-61.
26. Uchida T, Inaoki M, Makino E, Fujimoto W.
Identification of a recurrent mutation in keratin 17 in a Japanese family with pachyonychia congenita type 2. J Dermatol Sci. 2005 Apr;38(1):60-3.
27. Inaoki M, Uchida T, Sasae M, Hayashi H, Fujimoto W.
Improvement of psoriatic erythroderma by combination therapy consisting of systemic etretinate and a corticosteroid, photochemotherapy, and a topical corticosteroid and vitamin D3. Kawasaki Med J.2004. 30:37-42.
28. Makino E, Sakaguchi M, Iwatsuki K, Huh NH.
Introduction of an N-terminal peptide of S100C/A11 into human cells induces apoptotic cell death. J Mol Med 2004. 82:612-20
29. Miyashita Y, Yamaguchi M, Fujimoto W.
Painful indurated erythema suggestive of Kikuchi-Fujimoto disease in a patient with primary Sjogren's syndrome.J Dermatol. 2003 Aug;30(8):608-11.
   
 川崎医科大学附属病院 皮膚科 〒701-0192  岡山県倉敷市松島577